Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zhejiang CONBA Pharmaceutical Co Ltd Obtains GMP Permit


Wednesday, 13 Nov 2013 07:00pm EST 

Zhejiang CONBA Pharmaceutical Co Ltd announced that it has obtained a goods manufacturing practice (GMP) permit from Zhejiang Food and Drug Administration, for its tablet, capsule, granule, nose drops, ointments and cream preparation products, with a valid period until October 22, 2018. 

Company Quote

15.4
-0.01 -0.06%
28 Jul 2014